-
1
-
-
0014661330
-
Treatment for multiple myeloma. Combination chemotherapy with different melphalan dose regimens
-
Alexanian, R., Haut, A., Khan, A.U., Lane, M., McKelvey, E.M., Migliore, P.J., Stuckey, Jr, W.J. & Wilson. H.E. (1969) Treatment for multiple myeloma. Combination chemotherapy with different melphalan dose regimens. Journal of the American Medical Association, 208, 1680-1685.
-
(1969)
Journal of the American Medical Association
, vol.208
, pp. 1680-1685
-
-
Alexanian, R.1
Haut, A.2
Khan, A.U.3
Lane, M.4
McKelvey, E.M.5
Migliore, P.J.6
Stuckey W.J., Jr.7
Wilson, H.E.8
-
2
-
-
0036356546
-
High intensity regimens with autologous hematopoietic stem cell transplantation as treatment of multiple myeloma
-
Awedan, A.A. (2002) High intensity regimens with autologous hematopoietic stem cell transplantation as treatment of multiple myeloma. Annals of Transplantation, 7, 38-43.
-
(2002)
Annals of Transplantation
, vol.7
, pp. 38-43
-
-
Awedan, A.A.1
-
3
-
-
0035045698
-
High-dose therapy and innovative approaches to treatment of multiple myeloma
-
Barlogie, B. (2001) High-dose therapy and innovative approaches to treatment of multiple myeloma. Seminars in Hematology, 38, 21-27.
-
(2001)
Seminars in Hematology
, vol.38
, pp. 21-27
-
-
Barlogie, B.1
-
4
-
-
0007176749
-
Phase I evaluation of high dose melphalan, DITC and treosulfan (MDT) in previously treated metastatic breast and ovarian cancer
-
Abstract no. 585
-
Baynes, R.D., Parchment, R., Dansey, R.D., Klein, J., Karanes, C., Harem, C., Abella, E., Cassels, L., LeVeque, G., Baumgart, J., Bach, F. & Peters. W. (2000) Phase I evaluation of high dose melphalan, DITC and treosulfan (MDT) in previously treated metastatic breast and ovarian cancer. Proceedings ASCO, 19, Abstract no. 585.
-
(2000)
Proceedings ASCO
, vol.19
-
-
Baynes, R.D.1
Parchment, R.2
Dansey, R.D.3
Klein, J.4
Karanes, C.5
Harem, C.6
Abella, E.7
Cassels, L.8
LeVeque, G.9
Baumgart, J.10
Bach, F.11
Peters, W.12
-
5
-
-
0036227110
-
Allogeneic hematopoietic cell transplantation for multiple myeloma
-
Bensinger, W.I. (2002) Allogeneic hematopoietic cell transplantation for multiple myeloma. Biomedical Pharmacotherapeutics. 56, 133-138.
-
(2002)
Biomedical Pharmacotherapeutics
, vol.56
, pp. 133-138
-
-
Bensinger, W.I.1
-
6
-
-
0000597827
-
Stereoisomere 1,4-di-O-methansulfonyl-butan-1,2,3,4-tetrole
-
Feit, P.W. (1961) Stereoisomere 1,4-di-O-methansulfonyl-butan-1,2,3,4-tetrole. Tetrahedron Letters, 20, 716-717.
-
(1961)
Tetrahedron Letters
, vol.20
, pp. 716-717
-
-
Feit, P.W.1
-
7
-
-
0032191382
-
Treosulfan as an effective second-line therapy in ovarian cancer
-
Gropp, M., Meier, W. & Hepp, H. (1998) Treosulfan as an effective second-line therapy in ovarian cancer. Gynecological Oncology, 71, 94-98.
-
(1998)
Gynecological Oncology
, vol.71
, pp. 94-98
-
-
Gropp, M.1
Meier, W.2
Hepp, H.3
-
8
-
-
0036122482
-
Current treatment strategies for multiple myeloma
-
Grosbois, B., Decaux, O., Azais, I., Facon, T. & Avet-Loiseau, H. (2002) Current treatment strategies for multiple myeloma. European Journal of Internal Medicine, 13, 85-95.
-
(2002)
European Journal of Internal Medicine
, vol.13
, pp. 85-95
-
-
Grosbois, B.1
Decaux, O.2
Azais, I.3
Facon, T.4
Avet-Loiseau, H.5
-
9
-
-
0029929980
-
A phase I dose escalation trial of intravenous treosulfan in refractory cancer
-
Harstrick, A., Wilke, H. & Eberhardt, W. (1996) A phase I dose escalation trial of intravenous treosulfan in refractory cancer. Onkologie, 19, 153-156.
-
(1996)
Onkologie
, vol.19
, pp. 153-156
-
-
Harstrick, A.1
Wilke, H.2
Eberhardt, W.3
-
10
-
-
0026573505
-
Differentiation and retrodifferentiation of human myeloid leukemia cells is associated with reversible induction of cell cycle-regulatory genes
-
Hass, R., Gunji, H., Datta, R., Kharbanda, S., Hartmann, A., Weichselbaum, R. & Kufe, D. (1992) Differentiation and retrodifferentiation of human myeloid leukemia cells is associated with reversible induction of cell cycle-regulatory genes. Cancer Research, 52, 1445-1450.
-
(1992)
Cancer Research
, vol.52
, pp. 1445-1450
-
-
Hass, R.1
Gunji, H.2
Datta, R.3
Kharbanda, S.4
Hartmann, A.5
Weichselbaum, R.6
Kufe, D.7
-
11
-
-
0031831211
-
Clinical pharmacokinetics of intravenous treosulfan in patients with advanced solid tumors
-
Hilger, R.A., Harstrick, A., Eberhardt, W., Oberhoff, C., Skorzec, M., Baumgart, J., Seeber, S. & Scheulen, M.E. (1998) Clinical pharmacokinetics of intravenous treosulfan in patients with advanced solid tumors. Cancer Chemotherapy and Pharmacology. 42, 99-104.
-
(1998)
Cancer Chemotherapy and Pharmacology
, vol.42
, pp. 99-104
-
-
Hilger, R.A.1
Harstrick, A.2
Eberhardt, W.3
Oberhoff, C.4
Skorzec, M.5
Baumgart, J.6
Seeber, S.7
Scheulen, M.E.8
-
12
-
-
0023920752
-
Quantifying the carcinogenicity of antineoplastic drugs
-
Kaldor, J.M., Day, N.E. & Hemminki, K. (1988) Quantifying the carcinogenicity of antineoplastic drugs. European Journal of Cancer and Clinical Oncology, 24, 703-711.
-
(1988)
European Journal of Cancer and Clinical Oncology
, vol.24
, pp. 703-711
-
-
Kaldor, J.M.1
Day, N.E.2
Hemminki, K.3
-
13
-
-
0025023493
-
Leukemia following chemotherapy for ovarian cancer
-
Kaldor, J.M., Day, N.E., Pettersson, F., Clarke, E.A., Pedersen, D., Mehnert, W., Bell, J., Host, H., Prior, P. & Karjalainen, S. (1990) Leukemia following chemotherapy for ovarian cancer. New England Journal of Medicine, 322, 1-6.
-
(1990)
New England Journal of Medicine
, vol.322
, pp. 1-6
-
-
Kaldor, J.M.1
Day, N.E.2
Pettersson, F.3
Clarke, E.A.4
Pedersen, D.5
Mehnert, W.6
Bell, J.7
Host, H.8
Prior, P.9
Karjalainen, S.10
-
14
-
-
0029655838
-
Antitumor activity of treosulfan in human lung carcinomas
-
Kopf-Maier, P. & Sass, G. (1996) Antitumor activity of treosulfan in human lung carcinomas. Cancer Chemotherapy and Pharmacology, 37, 211-221.
-
(1996)
Cancer Chemotherapy and Pharmacology
, vol.37
, pp. 211-221
-
-
Kopf-Maier, P.1
Sass, G.2
-
15
-
-
0032803575
-
Treosulfan is an effective alkylating cytostatic for malignant melanoma in vitro and in vivo
-
Neuber, K., tom Dieck, A., Blodom-Schlicht, N., Itschert, G. & Kambach, C. (1999) Treosulfan is an effective alkylating cytostatic for malignant melanoma in vitro and in vivo. Melanoma Research, 9, 125-132.
-
(1999)
Melanoma Research
, vol.9
, pp. 125-132
-
-
Neuber, K.1
Tom Dieck, A.2
Blodom-Schlicht, N.3
Itschert, G.4
Kambach, C.5
-
16
-
-
0023764274
-
Renal clearance and protein binding of melphalan in patients with cancer
-
Reece, P.A., Hill, H.S., Green, R.M., Morris, R.G., Dale, B.M., Kotasek, D. & Sage, R.E. (1988) Renal clearance and protein binding of melphalan in patients with cancer. Cancer Chemotherapy and Pharmacology, 22, 348-352.
-
(1988)
Cancer Chemotherapy and Pharmacology
, vol.22
, pp. 348-352
-
-
Reece, P.A.1
Hill, H.S.2
Green, R.M.3
Morris, R.G.4
Dale, B.M.5
Kotasek, D.6
Sage, R.E.7
-
17
-
-
0033748741
-
Clinical phase I dose escalation and pharmacokinetic study of high-dose chemotherapy with treosulfan and autologous peripheral blood stem cell transplantation in patients with advanced malignancies
-
Scheulen, M.E., Hilger, R.A., Oberhoff, C., Casper, J., Freund, M., Josten, K.M., Bornhauser, M., Ehninger, G., Berdel, W.E., Baumgart, J., Harstrick, A., Bojko, P., Wolf, H.H., Schindler, A.E. & Seeber, S. (2000) Clinical phase I dose escalation and pharmacokinetic study of high-dose chemotherapy with treosulfan and autologous peripheral blood stem cell transplantation in patients with advanced malignancies. Clinical Cancer Research, 6, 4209-4216.
-
(2000)
Clinical Cancer Research
, vol.6
, pp. 4209-4216
-
-
Scheulen, M.E.1
Hilger, R.A.2
Oberhoff, C.3
Casper, J.4
Freund, M.5
Josten, K.M.6
Bornhauser, M.7
Ehninger, G.8
Berdel, W.E.9
Baumgart, J.10
Harstrick, A.11
Bojko, P.12
Wolf, H.H.13
Schindler, A.E.14
Seeber, S.15
-
18
-
-
0034486554
-
Treosulfan chemotherapy for recurrent malignant glioma
-
Schmidt, F., Wick, W., Herrlinger, U., Dichgans, J. & Weller, M. (2000) Treosulfan chemotherapy for recurrent malignant glioma. Journal of Neurooncology, 49, 231-234.
-
(2000)
Journal of Neurooncology
, vol.49
, pp. 231-234
-
-
Schmidt, F.1
Wick, W.2
Herrlinger, U.3
Dichgans, J.4
Weller, M.5
-
19
-
-
0003306132
-
Dose-escalation of treosulfan in a high-dose protocol: A classical alkylating agent new in high-dose combination chemotherapy
-
Abstract No 208
-
Wagner, H.M., Baumgart, J., Andreesen, R. & Reichle, A. (2000) Dose-escalation of treosulfan in a high-dose protocol: a classical alkylating agent new in high-dose combination chemotherapy. Proceedings ASCO, 19, Abstract No 208.
-
(2000)
Proceedings ASCO
, vol.19
-
-
Wagner, H.M.1
Baumgart, J.2
Andreesen, R.3
Reichle, A.4
-
21
-
-
0021968583
-
Decreased membrane potential of T lymphocytes in ageing mice: Flow cytometric studies with a carbocyanine dye
-
Witkowski, J. & Micklem, H.S. (1985) Decreased membrane potential of T lymphocytes in ageing mice: flow cytometric studies with a carbocyanine dye. Immunology, 56, 307-313.
-
(1985)
Immunology
, vol.56
, pp. 307-313
-
-
Witkowski, J.1
Micklem, H.S.2
|